11-5226598-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000518.5(HBB):c.294C>G(p.His98Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H98?) has been classified as Pathogenic.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.294C>G | p.His98Gln | missense_variant | 2/3 | ENST00000335295.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.294C>G | p.His98Gln | missense_variant | 2/3 | 1 | NM_000518.5 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 27, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jan 31, 2019 | Not found in the total gnomAD dataset, and the data are high quality. Predicted to have a damaging effect on the protein. Assessment of experimental evidence suggests this variant results in abnormal protein function. Moderate co-segregation with disease. - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 03, 2020 | The HBB c.294C>G; p.His98Gln variant (rs34515413), also known as Hb Malmo, is reported in the literature in multiple individuals affected with erythrocytosis (Santbergen 2014, HbVar and references therein). Additionally, other variants at this codon (c.294C>A; p.His98Gln, Hb Malmo and c.293A>T; p.His98Leu, Hb Wood) have been reported in individuals with erythrocytosis and are considered pathogenic (HbVar and references therein). The c.294C>G; p.His98Gln variant is reported in ClinVar (Variation ID: 15259), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. The histidine at codon 98 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL 0.872). Based on available information, the Hb Malmo variant is considered to be pathogenic. References: Link to HbVar for Hb Malmo: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=444&.cgifields=histD Link to HbVar for Hb Wood: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=445&.cgifields=histD Santbergen B et al. At high altitude in the Netherlands: secondary erythrocytosis due to HB-Malmo. BMJ Case Rep. 2014 Mar 5;2014. pii: bcr2014203701. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at